HAYWARD, Calif.--Lynx Therapeutics and Hybrigenics of Paris are working together to discover expressed genes, protein interactions, and pathways in human obesity. Both companies intend to use the findings to create new diagnostics and treatments for this disease area.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.